德英生物科技

Important resolutions of the Board of Directors in 2017

Important Resolutions of the Board of Directors in 2017 (Year 106)

▌Note: The table can be scrolled horizontally
Date Meeting Main Agenda Resolution
2017.03.18 1st Board Meeting Agenda 1: The Company’s 2016 Financial Statements submitted for review. With no objection from all attending directors, the proposal was approved. After accountants 林委好 and 林永智 of PwC Taiwan complete the audit and certification of the Company’s 2016 financial statements, the case will be submitted to the shareholders’ meeting for acknowledgment.
Agenda 2: The Company’s 2016 Business Report and Statement of Loss Compensation submitted for discussion. The proposal was approved with no objections from all attending directors and will be submitted to the shareholders’ meeting for acknowledgment.
Agenda 3: Completion of the Company’s 2016 Internal Control Self-Assessment and issuance of the Internal Control System Statement submitted for discussion. The proposal was approved with no objections from all attending directors.
Agenda 4: Amendments to the Company’s Internal Control System submitted for discussion. The amendments to the Company’s Internal Control System were approved with no objections from all attending directors.
Agenda 5: Amendments to the Company’s Procedures for Acquisition or Disposal of Assets submitted for discussion. The amendments to the Company’s “Procedures for Acquisition or Disposal of Assets” were approved with no objections from all attending directors and will be submitted to the shareholders’ meeting for discussion.
Agenda 6: Amendments to the Company’s Corporate Governance Best Practice Principles submitted for discussion. The amendments to the Company’s “Corporate Governance Best Practice Principles” were approved with no objections from all attending directors.
Agenda 7: Change of the Company’s address and establishment of the Guike Branch submitted for discussion. The proposal regarding the change of address and establishment of the Guike Branch was approved with no objections from all attending directors.
Agenda 8: Arrangements for convening the 2017 Annual Shareholders’ Meeting submitted for discussion. The proposal was approved with no objections from all attending directors.
2017.04.28 2nd Board Meeting Agenda 1: Amendments to certain provisions of the Company’s Articles of Incorporation submitted for discussion. To coordinate with the relocation of the Company’s headquarters plant to Tainan Science Industrial Park (Address: No. 92, Keji 5th Rd., Annan Dist., Tainan City), the amendments to the Company’s Articles of Incorporation were approved with no objections from all attending directors.
Agenda 2: Addition of agenda items to the 2017 Annual Shareholders’ Meeting notice submitted for discussion. The proposal was approved with no objections from all attending directors.
2017.08.04 3rd Board Meeting Agenda 1: Amendments to the Company’s Internal Control System, as described, submitted for discussion. The amendments to the Company’s Internal Control System were approved with no objections from all attending directors.
Agenda 2: Ratification of the installation and construction project for heating equipment at the new plant submitted for discussion. The ratification of the installation and construction of heating equipment at the new plant was approved with no objections from all attending directors.
Agenda 3: By-election of a member of the Remuneration Committee submitted for discussion. With no objections from all attending directors, it was resolved to elect Dr. 黃俊耀 as a member of the Company’s Remuneration Committee.
2017.11.03 4th Board Meeting Agenda 1: Amendments to the Company’s Internal Control System and Customer Credit Management Guidelines, as described, submitted for discussion. The amendments to the Company’s Internal Control System and “Customer Credit Management Guidelines” were approved with no objections from all attending directors.
Agenda 2: To comply with the “MOEA A+ Enterprise Innovation R&D Program” and the relevant subsidy regulations for encouraging technological innovation in key industries, the Company will provide a bank performance guarantee, submitted for discussion. The proposal was approved with no objections from all attending directors.
2017.12.14 5th Board Meeting Agenda 1: Establishment of the Company’s 2018 Budget submitted for discussion. The Company’s 2018 Budget was approved with no objections from all attending directors.
Agenda 2: Establishment of the Company’s 2018 Audit Plan submitted for discussion. The Company’s 2018 Audit Plan was approved with no objections from all attending directors.
Agenda 3: Amendments to the Company’s Remuneration Committee Charter submitted for discussion. The amendments to the Company’s “Remuneration Committee Charter” were approved with no objections from all attending directors.
Agenda 4: Establishment of the Company’s Regulations for Board Performance Evaluation submitted for discussion. The establishment of the Company’s “Regulations for Board Performance Evaluation” was approved with no objections from all attending directors.